Dashboard
Manage Tickers

IMNMImmunome Inc.

Nasdaq immunome.com


$ 15.31 $ -0.26 (-1.67 %)    

Wednesday, 21-Aug-2024 14:30:09 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 483.19 $ 2.07 (0.43 %)
DIA $ 409.22 $ -0.01 (-0 %)
SPY $ 561.34 $ 1.41 (0.25 %)
TLT $ 99.18 $ 0.50 (0.51 %)
GLD $ 232.83 $ 1.17 (0.51 %)
$ 15.21
$ 15.57
$ 14.75 x 205
$ 15.33 x 100
$ 14.79 - $ 15.57
$ 6.13 - $ 30.96
486,172
na
911.64M
$ 1.61
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-28-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-09-2023 06-30-2023 10-Q
6 05-05-2023 03-31-2023 10-Q
7 03-16-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-05-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-28-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-16-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
16 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wedbush-reiterates-outperform-on-immunome-maintains-33-price-target
Wedbush Reiterates Outperform on Immunome,...
08/13/2024 13:06:40

Wedbush analyst David Nierengarten reiterates Immunome (NASDAQ:IMNM) with a Outperform and maintains $33 price target.

piper-sandler-maintains-overweight-on-immunome-lowers-price-target-to-23
Piper Sandler Maintains Overweight on Immu...
08/13/2024 11:25:37

Piper Sandler analyst Biren Amin maintains Immunome (NASDAQ:IMNM) with a Overweight and lowers the price target from $27 to ...

immunome-q2-eps-060-misses-039-estimate-sales-236m-miss-255m-estimate
Immunome Q2 EPS $(0.60) Misses $(0.39) Est...
08/12/2024 20:02:38

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.39) by...

Core News & Articles
CORRECTION: Imunon Ticker Is "IMNN"
07/29/2024 20:31:47

nectin-therapeutics-enters-global-exclusive-license-agreement-with-immunome-immunome-receives-exclusive-rights-to-panel-of-antibodies-targeting-an-undisclosed-target
Nectin Therapeutics Enters Global, Exclusi...
07/25/2024 11:41:52

Under the terms of the agreement, Nectin granted Immunome an exclusive, worldwide, all-fields license to monoclonal antibodies ...

evaluating-immunome-insights-from-4-financial-analysts
Evaluating Immunome: Insights From 4 Finan...
05/31/2024 13:00:25

piper-sandler-initiates-coverage-on-immunome-with-overweight-rating-announces-price-target-of-27
Piper Sandler Initiates Coverage On Immuno...
05/31/2024 09:58:23

Piper Sandler analyst Biren Amin initiates coverage on Immunome (NASDAQ:IMNM) with a Overweight rating and announces Price T...

over-13m-bet-on-profrac-holding-check-out-these-4-stocks-insiders-are-buying
Over $13M Bet On ProFrac Holding? Check Ou...
05/22/2024 13:09:28

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 20:31:00

immunome-form-4-filing-shows-president-and-ceo-clay-b-siegall-bought-100000-shares-of-stock-at-a-price-of-1388share
Immunome Form 4 Filing Shows President And...
05/21/2024 20:27:08

-  SEC Filing

immunome-promotes-max-rosett-to-cfo-effective-may-9
Immunome Promotes Max Rosett To CFO, Effec...
05/17/2024 12:05:01

Rosett most recently held the role of Executive Vice President, Operations, in addition to serving as Immunome's Interim Ch...

immunome-q1-eps-251-misses-069-estimate-sales-103m-miss-250m-estimate
Immunome Q1 EPS $(2.51) Misses $(0.69) Est...
05/14/2024 12:18:20

Immunome (NASDAQ:IMNM) reported quarterly losses of $(2.51) per share which missed the analyst consensus estimate of $(0.69) by...

correction-immunome-did-not-report-q1-earnings-on-may-13-2024
CORRECTION: Immunome Did Not Report Q1 Ear...
05/13/2024 12:25:36

jp-morgan-initiates-coverage-on-immunome-with-overweight-rating-announces-price-target-of-24
JP Morgan Initiates Coverage On Immunome w...
04/30/2024 12:45:00

JP Morgan analyst Brian Cheng initiates coverage on Immunome (NASDAQ:IMNM) with a Overweight rating and announces Price Targ...

guggenheim-initiates-coverage-on-immunome-with-buy-rating-announces-price-target-of-35
Guggenheim Initiates Coverage On Immunome ...
04/15/2024 10:34:05

Guggenheim analyst Michael Schmidt initiates coverage on Immunome (NASDAQ:IMNM) with a Buy rating and announces Price Target...

immunome-files-for-shelf-of-up-to-22m-shares-of-common-stock-by-selling-stockholder
Immunome Files For Shelf Of Up To 2.2M Sha...
04/03/2024 20:51:13

- SEC Filing

immunome-inc-filed-prospectus-relates-to-proposed-resale-from-time-to-time-by-selling-stockholder-of-23m-shares-or-shares-of-common-stock
Immunome Inc Filed Prospectus Relates To P...
04/03/2024 20:49:31

- SEC Filing

wedbush-maintains-outperform-on-immunome-raises-price-target-to-33
Wedbush Maintains Outperform on Immunome, ...
04/01/2024 11:58:37

Wedbush analyst David Nierengarten maintains Immunome (NASDAQ:IMNM) with a Outperform and raises the price target from $27 t...

immunome-q4-adj-eps-015-beats-028-estimate-sales-383m-beat-207m-estimate
Immunome Q4 Adj EPS $(0.15) Beats $(0.28) ...
03/29/2024 03:37:37

Immunome (NASDAQ:IMNM) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.28) by 4...

stocks-pause-as-traders-reassess-interest-rate-path-gold-makes-new-highs-bitcoin-rebounds-whats-driving-markets-thursday
Stocks Pause As Traders Reassess Interest ...
03/28/2024 17:49:57

In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting so...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION